MAPT and Alzheimer disease: ASOs targeting mutated tau proteins, ASOs increasing the expression of BDNF, other ASOs removing the amyloid plaque, and gene therapy to decrease the expression of APOE4 are currently under different investigative stages for the treatment of AD.